Pay in 4 interest-free payments of $5.45 Learn more
Ships within 48 hours · Estimated delivery Aug 23 - Aug 28
Psychiatry 6 , e951 (2016)
Possibly, but this should be clinician-guided
We model these honestly at consult so patients understand the lifetime commitment rather than chasing single-visit prices
In a multicenter, randomized, placebo-controlled dose-finding trial, cagrilintide at doses ranging from 0.3 to 4.5 mg weekly produced dose-dependent weight reductions, with the 4.5 mg dose achieving approximately 10.8% weight loss at 26 weeks compared to 3.0% with placebo
Ethics declarations Ethics Approval and Consent to Participate Written informed consent was obtained from all individual participants included in the study
US$ 23.91
US$ 26.26
US$ 23.29
